Fibrinolytic therapy for thrombosis in cardiac valvular prosthesis short and long term results
OBJECTIVE: To assess the short- and long-term results of the use of streptokinase (SK) for the treatment of thromboses in cardiac valvular prostheses. METHODS: Seventeen patients with cardiac prosthetic thrombosis diagnosed by clinical, echocardiographic, and radioscopic findings underwent fibrinolytic treatment with a streptokinase bolus of 250,000 U followed by 100.000 U/hour. Short- and long-term results were assessed by radioscopy and echocardiography. RESULTS: Of the 17 patients, 12 had mechanical double-disk prostheses (4 aortic, 6 mitral, 2 tricuspid), 4 had single-disk prostheses (2 aortic, 1 mitral, and 1 tricuspid), and 1 had a tricuspid bioprosthesis. The success rate was 64.8%, the partial success rate was 17.6%, and the nonsuccess rate was 17.6%. All patients with a double-disk prosthesis responded, completely or partially, to the treatment. None of the patients with a single-disk prosthesis had complete resolution of the thrombosis. The time of streptokinase infusion ranged from 6 to 80 hours (mean of 56 h). The mortality rate due to the use of streptokinase was 5.8% and was secondary to cerebral bleeding. During streptokinase infusion, 3 (17.6%) embolic episodes occurred as follows: 1 cerebral, 1 peripheral, and 1 coronary. The rethrombosis index was 33% in a mean follow-up of 42 months. CONCLUSION: The use of fibrinolytic agents was effective and relatively safe in patients with primary thrombosis of a double-disk prosthesis. A fatal hemorrhagic complication occurred in 1 (5.8%) patient, and embolic complications occurred in 3 (17.6%) patients. In a mean 42-month follow-up, 67% of the patients were free from rethrombosis.
Main Authors: | , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Cardiologia - SBC
2003
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2003001200006 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0066-782X2003001200006 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0066-782X20030012000062003-11-05Fibrinolytic therapy for thrombosis in cardiac valvular prosthesis short and long term resultsRamos,Auristela I. O.Ramos,Rui F.Togna,Dorival J. D.Arnoni,Antoninho S.Staico,RodolfoGalo,Mercedes M.Meneghelo,Zilda M. fibrinolytic therapy thrombosis streptokinase cardiac valvular prostheses OBJECTIVE: To assess the short- and long-term results of the use of streptokinase (SK) for the treatment of thromboses in cardiac valvular prostheses. METHODS: Seventeen patients with cardiac prosthetic thrombosis diagnosed by clinical, echocardiographic, and radioscopic findings underwent fibrinolytic treatment with a streptokinase bolus of 250,000 U followed by 100.000 U/hour. Short- and long-term results were assessed by radioscopy and echocardiography. RESULTS: Of the 17 patients, 12 had mechanical double-disk prostheses (4 aortic, 6 mitral, 2 tricuspid), 4 had single-disk prostheses (2 aortic, 1 mitral, and 1 tricuspid), and 1 had a tricuspid bioprosthesis. The success rate was 64.8%, the partial success rate was 17.6%, and the nonsuccess rate was 17.6%. All patients with a double-disk prosthesis responded, completely or partially, to the treatment. None of the patients with a single-disk prosthesis had complete resolution of the thrombosis. The time of streptokinase infusion ranged from 6 to 80 hours (mean of 56 h). The mortality rate due to the use of streptokinase was 5.8% and was secondary to cerebral bleeding. During streptokinase infusion, 3 (17.6%) embolic episodes occurred as follows: 1 cerebral, 1 peripheral, and 1 coronary. The rethrombosis index was 33% in a mean follow-up of 42 months. CONCLUSION: The use of fibrinolytic agents was effective and relatively safe in patients with primary thrombosis of a double-disk prosthesis. A fatal hemorrhagic complication occurred in 1 (5.8%) patient, and embolic complications occurred in 3 (17.6%) patients. In a mean 42-month follow-up, 67% of the patients were free from rethrombosis.info:eu-repo/semantics/openAccessSociedade Brasileira de Cardiologia - SBCArquivos Brasileiros de Cardiologia v.81 n.4 20032003-10-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2003001200006en10.1590/S0066-782X2003001200006 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Ramos,Auristela I. O. Ramos,Rui F. Togna,Dorival J. D. Arnoni,Antoninho S. Staico,Rodolfo Galo,Mercedes M. Meneghelo,Zilda M. |
spellingShingle |
Ramos,Auristela I. O. Ramos,Rui F. Togna,Dorival J. D. Arnoni,Antoninho S. Staico,Rodolfo Galo,Mercedes M. Meneghelo,Zilda M. Fibrinolytic therapy for thrombosis in cardiac valvular prosthesis short and long term results |
author_facet |
Ramos,Auristela I. O. Ramos,Rui F. Togna,Dorival J. D. Arnoni,Antoninho S. Staico,Rodolfo Galo,Mercedes M. Meneghelo,Zilda M. |
author_sort |
Ramos,Auristela I. O. |
title |
Fibrinolytic therapy for thrombosis in cardiac valvular prosthesis short and long term results |
title_short |
Fibrinolytic therapy for thrombosis in cardiac valvular prosthesis short and long term results |
title_full |
Fibrinolytic therapy for thrombosis in cardiac valvular prosthesis short and long term results |
title_fullStr |
Fibrinolytic therapy for thrombosis in cardiac valvular prosthesis short and long term results |
title_full_unstemmed |
Fibrinolytic therapy for thrombosis in cardiac valvular prosthesis short and long term results |
title_sort |
fibrinolytic therapy for thrombosis in cardiac valvular prosthesis short and long term results |
description |
OBJECTIVE: To assess the short- and long-term results of the use of streptokinase (SK) for the treatment of thromboses in cardiac valvular prostheses. METHODS: Seventeen patients with cardiac prosthetic thrombosis diagnosed by clinical, echocardiographic, and radioscopic findings underwent fibrinolytic treatment with a streptokinase bolus of 250,000 U followed by 100.000 U/hour. Short- and long-term results were assessed by radioscopy and echocardiography. RESULTS: Of the 17 patients, 12 had mechanical double-disk prostheses (4 aortic, 6 mitral, 2 tricuspid), 4 had single-disk prostheses (2 aortic, 1 mitral, and 1 tricuspid), and 1 had a tricuspid bioprosthesis. The success rate was 64.8%, the partial success rate was 17.6%, and the nonsuccess rate was 17.6%. All patients with a double-disk prosthesis responded, completely or partially, to the treatment. None of the patients with a single-disk prosthesis had complete resolution of the thrombosis. The time of streptokinase infusion ranged from 6 to 80 hours (mean of 56 h). The mortality rate due to the use of streptokinase was 5.8% and was secondary to cerebral bleeding. During streptokinase infusion, 3 (17.6%) embolic episodes occurred as follows: 1 cerebral, 1 peripheral, and 1 coronary. The rethrombosis index was 33% in a mean follow-up of 42 months. CONCLUSION: The use of fibrinolytic agents was effective and relatively safe in patients with primary thrombosis of a double-disk prosthesis. A fatal hemorrhagic complication occurred in 1 (5.8%) patient, and embolic complications occurred in 3 (17.6%) patients. In a mean 42-month follow-up, 67% of the patients were free from rethrombosis. |
publisher |
Sociedade Brasileira de Cardiologia - SBC |
publishDate |
2003 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2003001200006 |
work_keys_str_mv |
AT ramosauristelaio fibrinolytictherapyforthrombosisincardiacvalvularprosthesisshortandlongtermresults AT ramosruif fibrinolytictherapyforthrombosisincardiacvalvularprosthesisshortandlongtermresults AT tognadorivaljd fibrinolytictherapyforthrombosisincardiacvalvularprosthesisshortandlongtermresults AT arnoniantoninhos fibrinolytictherapyforthrombosisincardiacvalvularprosthesisshortandlongtermresults AT staicorodolfo fibrinolytictherapyforthrombosisincardiacvalvularprosthesisshortandlongtermresults AT galomercedesm fibrinolytictherapyforthrombosisincardiacvalvularprosthesisshortandlongtermresults AT meneghelozildam fibrinolytictherapyforthrombosisincardiacvalvularprosthesisshortandlongtermresults |
_version_ |
1756381492196409344 |